Articles | Volume 5, issue 1
J. Bone Joint Infect., 5, 28–34, 2020
https://doi.org/10.7150/jbji.40333
J. Bone Joint Infect., 5, 28–34, 2020
https://doi.org/10.7150/jbji.40333

Original full-length article 10 Feb 2020

Original full-length article | 10 Feb 2020

Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France

A. Becker et al.

Cited articles

El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG. et al. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. août. 2010;29(8):961–7.
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 20 mai. 1998;279(19):1537–41.
Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. avr. 2014;27(2):302–45. [PMC free article]
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. janv. 2013;56(1):e1–25.
Senneville E, Joulie D, Legout L, Valette M, Dezèque H, Beltrand E. et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis Off Publ Infect Dis Soc Am. août. 2011;53(4):334–40. [PMC free article]